US 9574192
Serapina1 iRNA compositions and methods of use thereof
granted A61KA61K31/712A61K31/713
Quick answer
US patent 9574192 (Serapina1 iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/712, A61K31/713, A61P, A61P1/00